Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We utilise our cutting-edge, exclusive workflow to develop focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
P49069
UPID:
CAMLG_HUMAN
Alternative names:
Calcium signal-modulating cyclophilin ligand
Alternative UPACC:
P49069; A1L3Y3
Background:
The Guided entry of tail-anchored proteins factor CAMLG, also known as Calcium signal-modulating cyclophilin ligand, plays a pivotal role in protein biosynthesis and cellular signaling. It is essential for the delivery of tail-anchored proteins to the endoplasmic reticulum, a process critical for maintaining cellular function and integrity. Additionally, CAMLG is involved in calcium signaling in T cells and is crucial for the survival of peripheral follicular B cells.
Therapeutic significance:
CAMLG's involvement in Congenital disorder of glycosylation 2Z, characterized by severe neurological symptoms and glycosylation defects, highlights its potential as a target for therapeutic intervention. Understanding the role of CAMLG could open doors to potential therapeutic strategies.